Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14955287 | 0.84 | SRC (0.57) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL14955046 | 0.84 | SRC (0.57) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL3250020 | 0.81 | SRC (0.53) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL1003234 | 0.81 | SRC (0.53) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL10633537 | 0.81 | SRC (0.53) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL1663424 | 0.81 | SRC (0.53) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL30600579 | 0.81 | CYP2C19 (0.41) | SRCALDH1A1CYP2D6CYP2C19TRPA1 | |
| SCHEMBL15617700 | 0.81 | TRPA1 (0.47) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL3398553 | 0.81 | SRC (0.53) | SRCALDH1A1CYP2D6CYP2C19LMNA | |
| SCHEMBL3398560 | 0.81 | SRC (0.53) | SRCALDH1A1CYP2D6CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101163763-A | Curable acrylate compositions, methods of making the compositions, and articles made therefrom | GEN ELECTRIC (US) | 2008-04-16 | — | — | CN | claimed |
| EP-0585071-B1 | Process for making sodium acylisethionates | HOECHST CELANESE CORP (US) | 1996-07-24 | — | — | EP | claimed |
| US-20120029197-A1 | Method for Preparing Sulfur-Containing Compounds | THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2012-02-02 | — | — | US | disclosed |
| US-20120029197-A1 | Method for Preparing Sulfur-Containing Compounds | THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2012-02-02 | — | — | US | disclosed |
| WO-2010066450-A1 | A METHOD FOR PREPARING SULFUR-CONTAINING COMPOUNDS | THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2010-06-17 | — | — | WO | disclosed |
| CN-101163763-A | Curable acrylate compositions, methods of making the compositions, and articles made therefrom | GEN ELECTRIC (US) | 2008-04-16 | — | — | CN | disclosed |
| EP-1236714-B1 | ACETALSULFONATE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING STYRENE OXIDE DERIVATIVE | MITSUBISHI RAYON CO (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-6642395-B1 | Esterifying mandelic acid derivative; protecting hydroxyl group and reducing ester; sulfonating and epoxidizing | MITSUBISHI RAYON CO., LTD. (JP) | 2003-11-04 | — | — | US | disclosed |
| EP-1236714-A1 | ACETALSULFONATE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING STYRENE OXIDE DERIVATIVE | Mitsubishi Rayon Co., Ltd. (JP) | 2002-09-04 | — | — | EP | disclosed |
| CN-1356323-A | Benzothiazolone derivative | ASTRAZENECA AB (SE) | 2002-07-03 | — | — | CN | disclosed |
| CN-1073098-C | Benzothiazolone derivatives | ASTRA ZENICA LTD (SE) | 2001-10-17 | — | — | CN | disclosed |
| CN-1202163-A | Benzothiazolone derivatives | ASTRA PHARMA PROD (GB) | 1998-12-16 | — | — | CN | disclosed |
| CN-1051367-A | The lactone polymerization of yttrium and catalysis of rare-earth compound | DU PONT (US) | 1991-05-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029197-A1 | Method for Preparing Sulfur-Containing Compounds | SULT1E1, SULT1A1, TST | SRC 937/4885ALDH1A1 195/4885CYP2D6 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.